文献速递流行病学与生物统计医学教育与科研方法

加沙地带免疫接种后不良事件监测系统评估:横断面研究

Assessment of the surveillance system for adverse events following immunisation in the Gaza Strip: a cross-sectional study.
PubMed 文献 · Lancet · 2021-01-01

本研究通过问卷、清单调查、深度访谈和焦点小组四种方法,评估加沙地带医务人员对免疫接种后不良事件(AEFI)监测系统的依从性。结果显示AEFI报告率低,约半数医务人员报告AEFI,但报告对象存在分歧;卫生机构结构不完善,缺乏指南、协议和报告表格,且医务人员害怕惩罚。研究建议加强培训、制定指南和建立监测系统。

要点

  • 仅约半数医务人员报告AEFI,报告对象存在分歧。
  • 缺乏指南、协议和报告表格是主要障碍之一。
  • 医务人员普遍需要进一步培训并加强机构间协调。

核心结论

  • 加沙地带AEFI监测系统依从性差,存在结构不完善、缺乏指南和报告表格、医务人员认识不足及害怕惩罚等问题。

研究设计与样本

  • 横断面研究,采用问卷(105名医务人员)、清单调查(24家卫生机构)、深度访谈(17名卫生官员和信息管理员)和焦点小组(22名流行病学家等)四种方法,数据收集于2015年6月至8月。

主要发现

  • 105名医务人员中51%(53名)报告AEFI,65%(68名)认为应报告所有AEFI。
  • 74%(78名)参加免疫接种研讨会,95%(100名)报告需要进一步培训。
  • 17名受访者均知晓必须报告AEFI,65%(11名)表示无困难,35%(6名)因缺乏指南、协议或报告表格及害怕惩罚而遇困难。

临床怎么用

  • 应鼓励医务人员报告不良事件而无惧惩罚,并开展培训、制定指南和协议、构建数据库及监测系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the occupied Palestinian territory, the expanded programme on immunisation (EPI) has successfully targeted 13 diseases through vaccination and achieved high population coverage. However, surveillance of adverse events following immunisation (AEFI) is inadequate in the Gaza Strip, as only post-BCG lymphadenitis is reported. This study assessed the adherence of health-care workers (HCWs) to the AEFI surveillance system in the Gaza Strip. METHODS: Data were collected by four methods: 105 HCWs answered a questionnaire; 24 health facilities completed a checklist enquiry; 17 medical health officers and information system managers from Ministry of Health (MOH) and UNRWA health centres and hospitals underwent in-depth interviews; and a focus group was held with 22 epidemiologists, stakeholders, consultants, and managers of the EPI. The 24 health facilities comprised seven MOH primary health-care centres (PHCs) providing vaccination, five MOH PHCs not providing vaccination, seven UNRWA PHCs, and the five hospitals of the Gaza Strip with paediatric departments. Data collected from June, 2015, to August, 2015, were analysed with SPSS version 19. Relationships among variables were assessed by independent t tests, chi squared tests and one-way ANOVA. Verbal informed consent was obtained from all participants, and written approval for the study was obtained from MOH and UNWRA directorates. FINDINGS: AEFI are reported infrequently; approximately half of the 105 HCWs (51%; 53) report AEFI, but there were conflicting views as to whom they should report. 65% (68) thought that they should report all AEFI. Participants' educational background, participation in workshops, and number of years of employment affected AEFI recognition and reporting. The majority (74%; 78) participate in immunisation workshops. There is an ineffective structure in MOH centres, and the UNRWA has a well-established internal system for reporting AEFI but a poor system for external reporting to the MOH epidemiology department. A lack of HCW awareness of responsibilities may also have a role. The majority of HCWs (95%; 100) reported a need for further training, and all reported a lack of cooperation or coordination between hospitals and PHCs regarding AEFI notification. All individuals (17) who were interviewed knew that they must report AEFI. A majority (65%; 11) stated no difficulties, whereas some (35%; six) reported difficulties due to absence of guidelines, protocols, or notification forms, and to fear of punishment. Focus group participants felt that all AEFI should be reported. They agreed that HCWs face obstacles such as fear of consequences, lack of knowledge and training, high workloads, not considering AEFI as related to immunisation, and absence or shortage of notification forms, protocols, and guidelines. Some felt that certain AEFI should be reported only to treating doctors, but all agreed that there is no cooperation or coordination among PHCs and between hospitals and PHCs regarding AEFI reporting. INTERPRETATION: Common themes may explain poor adherence of HCWs to AEFI surveillance. The system is ineffective in MOH centres, and UNRWA PHCs have well-established internal but poor external reporting systems. Absence of monitoring may have a role, and a lack of guidelines, protocols, and forms for reporting were mentioned by HCWs, medical health officers and information system managers, and the focus group. Some HCWs may not know their responsibilities (eg, to whom AEFI should be reported). Many other obstacles face HCWs, including fear of punishment and accountability. Therefore, HCWs must be encouraged to report adverse events without fear of penalty. In addition, lack of education on AEFI and lack of experience in identifying AEFI may affect reporting. Training of HCWs, development of guidelines and protocols, database construction and design, and monitoring of the AEFI surveillance system are highly recommended. FUNDING: WHO EMRO.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Awad JA, Dhair MI, Ghuneim NI, et al. Assessment of the surveillance system for adverse events following immunisation in the Gaza Strip: a cross-sectional study. Lancet. 2021. PMID: 34227959. doi:10.1016/S0140-6736(21)01513-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。